Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 2.452% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: COC(=O)C1CCN(C(=O)[C@H](C)NC(=O)C2CC(=O)N(c3ccc(F)cc3)C2)CC1
b: O=C(CSc1nnc(NC(=O)C2CC2)s1)Nc1ccccc1
c: Cc1onc(-c2ccccc2Cl)c1C(=O)N1CCN(c2ncccn2)CC1
d: CSC(=NC#N)N1CCN(c2c(C)cccc2C)CC1
e: COc1cc(C(=O)NC(CCSC)C(=O)OCC(=O)NC(=O)C2CCCCC2)cc(OC)c1OC
Answer: c. Cc1onc(-c2ccccc2Cl)c1C(=O)N1CCN(c2ncccn2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1onc(-c2ccccc2Cl)c1C(=O)N1CCN(c2ncccn2)CC1
Cc1onc(-c2ccccc2Cl)c1C(=O)N1CCN(c2ncccn2)CC1
[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]-(4-pyrimidin-2-ylpiperazin-1-yl)methanone